Methyltransferase inhibitors for treatment of COVID19

Funder	European Commission
Recipient Organization	Technische Universitaet Muenchen
Country	Germany
Start Date	Jun 01, 2022
End Date	Nov 30, 2023
Duration	547 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`101069369`

Grant Description

Our IP secured drug DZNep is effective in treating SARS-CoV-2 infections in preclinical disease models and uniquely suppresses virus growth, triggers the innate immunity and facilitates tissue regeneration. The ERC-PoC will enable the transition from preclinical to clinical research.